$OMDA

A live call on Omada Health's third-quarter results is scheduled for 4:30 p.m. ET Nov. 5.

Omada Health (Nasdaq: OMDA) will release its Q3 2026 results on Nov. 5 after market close and host a conference call at 4:30 p.m. ET. The call will be webcast live and a replay will be available for 12 months. Omada Health is a virtual healthcare provider focusing on chronic conditions.

Original reporting
Published Oct 13, 2026, 1:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 1:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The scheduled earnings call provides a clear date for market participants to plan trades; no substantive new information beyond timing is disclosed.

02

Market read

The article's primary value is informing traders of the Q3 earnings release schedule, enabling timing‑based positioning.

03

What to watch

Analysts may watch for any surprise guidance or commentary on the company's AI‑enabled care model during the call.

Relevance 5/10Novelty 4/10Timing: after‑hours on Nov 5, 2026

Background

Omada Health is a Nasdaq‑listed virtual care provider focusing on chronic‑condition management.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health announced the date and time of its Q3 2026 earnings release and conference call.

Expected impact

potential volatility around the after‑hours release as traders position for the earnings surprise.

Evidence & confidence

Earnings‑release schedules are standard catalysts; no new financial data is disclosed, so impact is limited to timing‑related positioning.

Market effects

None beyond the digital health sector, which may see modest attention ahead of the earnings call.

U.S. market participants may note the timing for pre‑market positioning.

Limited to investors tracking health‑tech stocks.

Counterpoint

With no new guidance, the call may be a routine filing and not a catalyst for price movement.

Key entities

  • Omada Health

    Nasdaq‑listed digital health provider (ticker OMDA).

Related articles

$OMDALowAI 8/10

Omada Health reports weight loss study results for GLP-1 program

Omada Health (NASDAQ:OMDA) presented a 12-week study at the World Obesity and Weight Management Congress, showing its GLP-1 Care Track program led to 6.0% average weight loss vs. 3.3% for usual care. The study, published in Diabetes, Obesity and Metabolism, involved 245 adults with obesity. Omada's program also improved body composition, well-being, and reduced depression/anxiety symptoms.

$OMDAHighAI 9/10

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

$OMDAHigh

Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch